BACKGROUND: As the population ages and critical care advances, a growing number of survivors of critical illness will be at risk for intensive care unit (ICU)-acquired weakness. Bed rest, which is common in the ICU, causes adverse effects, including muscle weakness. Consequently, patients need ICU-based interventions focused on the muscular system. Although emerging evidence supports the benefits of early rehabilitation during mechanical ventilation, additional therapies may be beneficial. Neuromuscular electrical stimulation (NMES), which can provide some muscular activity even very early during critical illness, is a promising modality for patients in the ICU. OBJECTIVE: The objectives of this article are to discuss the implications of bed rest for patients with critical illness, summarize recent studies of early rehabilitation and NMES in the ICU, and describe a protocol for a randomized, phase II pilot study of NMES in patients receiving mechanical ventilation. DESIGN: The study was a randomized, sham-controlled, concealed, phase II pilot study with caregivers and outcome assessors blinded to the treatment allocation. SETTING: The study setting will be a medical ICU. PARTICIPANTS: The study participants will be patients who are receiving mechanical ventilation for 1 day or more, who are expected to stay in the ICU for an additional 2 days or more, and who meet no exclusion criteria. INTERVENTION: The intervention will be NMES (versus a sham [control] intervention) applied to the quadriceps, tibialis anterior, and gastrocnemius muscles for 60 minutes per day. MEASUREMENTS: Lower-extremity muscle strength at hospital discharge will be the primary outcome measure. LIMITATIONS: Muscle strength is a surrogate measure, not a patient-centered outcome. The assessments will not include laboratory, genetic, or histological measures aimed at a mechanistic understanding of NMES. The optimal duration or dose of NMES is unclear. CONCLUSIONS: If NMES is beneficial, the results of the study will help advance research aimed at reducing the burden of muscular weakness and physical disability in survivors of critical illness.
RCT Entities:
BACKGROUND: As the population ages and critical care advances, a growing number of survivors of critical illness will be at risk for intensive care unit (ICU)-acquired weakness. Bed rest, which is common in the ICU, causes adverse effects, including muscle weakness. Consequently, patients need ICU-based interventions focused on the muscular system. Although emerging evidence supports the benefits of early rehabilitation during mechanical ventilation, additional therapies may be beneficial. Neuromuscular electrical stimulation (NMES), which can provide some muscular activity even very early during critical illness, is a promising modality for patients in the ICU. OBJECTIVE: The objectives of this article are to discuss the implications of bed rest for patients with critical illness, summarize recent studies of early rehabilitation and NMES in the ICU, and describe a protocol for a randomized, phase II pilot study of NMES in patients receiving mechanical ventilation. DESIGN: The study was a randomized, sham-controlled, concealed, phase II pilot study with caregivers and outcome assessors blinded to the treatment allocation. SETTING: The study setting will be a medical ICU. PARTICIPANTS: The study participants will be patients who are receiving mechanical ventilation for 1 day or more, who are expected to stay in the ICU for an additional 2 days or more, and who meet no exclusion criteria. INTERVENTION: The intervention will be NMES (versus a sham [control] intervention) applied to the quadriceps, tibialis anterior, and gastrocnemius muscles for 60 minutes per day. MEASUREMENTS: Lower-extremity muscle strength at hospital discharge will be the primary outcome measure. LIMITATIONS: Muscle strength is a surrogate measure, not a patient-centered outcome. The assessments will not include laboratory, genetic, or histological measures aimed at a mechanistic understanding of NMES. The optimal duration or dose of NMES is unclear. CONCLUSIONS: If NMES is beneficial, the results of the study will help advance research aimed at reducing the burden of muscular weakness and physical disability in survivors of critical illness.
Authors: Angela M Cheung; Catherine M Tansey; George Tomlinson; Natalia Diaz-Granados; Andrea Matté; Aiala Barr; Sangeeta Mehta; C David Mazer; Cameron B Guest; Thomas E Stewart; Fatma Al-Saidi; Andrew B Cooper; Deborah Cook; Arthur S Slutsky; Margaret S Herridge Journal: Am J Respir Crit Care Med Date: 2006-06-08 Impact factor: 21.405
Authors: Polly Bailey; George E Thomsen; Vicki J Spuhler; Robert Blair; James Jewkes; Louise Bezdjian; Kristy Veale; Larissa Rodriquez; Ramona O Hopkins Journal: Crit Care Med Date: 2007-01 Impact factor: 7.598
Authors: Margaret S Herridge; Angela M Cheung; Catherine M Tansey; Andrea Matte-Martyn; Natalia Diaz-Granados; Fatma Al-Saidi; Andrew B Cooper; Cameron B Guest; C David Mazer; Sangeeta Mehta; Thomas E Stewart; Aiala Barr; Deborah Cook; Arthur S Slutsky Journal: N Engl J Med Date: 2003-02-20 Impact factor: 91.245
Authors: Minxuan Huang; Kitty S Chan; Jennifer M Zanni; Selina M Parry; Saint-Clair G B Neto; Jose A A Neto; Vinicius Z M da Silva; Michelle E Kho; Dale M Needham Journal: Crit Care Med Date: 2016-12 Impact factor: 7.598
Authors: Michelle E Kho; Alexander D Truong; Jennifer M Zanni; Nancy D Ciesla; Roy G Brower; Jeffrey B Palmer; Dale M Needham Journal: J Crit Care Date: 2014-09-22 Impact factor: 3.425
Authors: Michelle E Kho; Alexander J Molloy; France Clarke; Margaret S Herridge; Karen K Y Koo; Jill Rudkowski; Andrew J E Seely; Joseph R Pellizzari; Jean-Eric Tarride; Marina Mourtzakis; Timothy Karachi; Deborah J Cook Journal: BMJ Open Date: 2016-04-08 Impact factor: 2.692
Authors: Michelle E Kho; Alexander J Molloy; France J Clarke; Daana Ajami; Magda McCaughan; Kristy Obrovac; Christina Murphy; Laura Camposilvan; Margaret S Herridge; Karen K Y Koo; Jill Rudkowski; Andrew J E Seely; Jennifer M Zanni; Marina Mourtzakis; Thomas Piraino; Deborah J Cook Journal: PLoS One Date: 2016-12-28 Impact factor: 3.240
Authors: Selina M Parry; Sue Berney; René Koopman; Adam Bryant; Doa El-Ansary; Zudin Puthucheary; Nicholas Hart; Stephen Warrillow; Linda Denehy Journal: BMJ Open Date: 2012-09-13 Impact factor: 2.692